Form 4 · Filed Jun 24, 2026, 08:17 PM UTC
CNTA/Centessa Pharmaceuticals plc
Bush Tia L — Chief Technology & Quality Ofc
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | D | other | 147,954 | — | — | 0 |
| Jun 24, 2026 | D | other | 360,338 | — | — | 0 |
| Jun 24, 2026 | D | other | 140,000 | — | — | 0 |
| Jun 24, 2026 | D | other | 27,187 | — | — | 0 |
| Jun 24, 2026 | D | other | 145,208 | — | — | 0 |
| Jun 24, 2026 | D | other | 125,000 | — | — | 0 |
| Jun 24, 2026 | D | other | 140,000 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001470831-26-000621